Gene Therapy Restores Hearing in Patients with Genetic Deafness

Breakthrough treatment delivers functional OTOF gene, dramatically improving auditory perception.

Apr. 1, 2026 at 6:36pm by Ben Kaplan

Got story updates? Submit your updates here. ›

A groundbreaking gene therapy study in China has successfully restored hearing in 10 patients, ages 1 to 24, who were suffering from genetic forms of deafness. By delivering a functional version of the OTOF gene, which is critical for transmitting auditory signals, researchers were able to improve patients' perceptible sound levels from 106 decibels down to just 52 decibels - a dramatic improvement that could be life-changing.

Why it matters

Genetic deafness affects millions worldwide, with over 120 genes linked to hearing loss. This study represents a major step forward in using gene therapies to treat the root causes of hereditary hearing impairment, potentially restoring normal or near-normal hearing for those affected.

The details

The gene therapy treatment involved injecting a synthetic adeno-associated virus (AAV) carrying a functional OTOF gene directly into the 'round window' membrane at the base of the cochlea. After just one month, patients began showing significant improvements in their hearing, with further gains observed over the following six months. The biggest improvements were seen in children ages 5-8, with one 7-year-old girl recovering nearly all of her hearing within four months.

  • The study was published in 2025.
  • The gene therapy treatment was tested on 10 patients between the ages of 1 and 24 at five hospitals throughout China.

The players

Maoli Duan

A co-author of the study and researcher at Karolinska Institutet in Sweden.

Got photos? Submit your photos here. ›

What they’re saying

“This is a huge step forward in the genetic treatment of deafness, one that can be life-changing for children and adults.”

— Maoli Duan, Researcher

What’s next

Researchers are now expanding their work to target other more common genes linked to genetic deafness, such as GJB2 and TMC1, which they believe will also yield promising results through gene therapy.

The takeaway

This breakthrough in using gene therapy to treat genetic forms of deafness represents a major medical advancement that could dramatically improve the lives of millions affected by hearing loss worldwide. While more research is needed to address the full spectrum of hereditary hearing impairment, this study offers hope that a future without genetic deafness may be within reach.